IP Library Granted Patent US 11,021,747
Granted Patent B2
US 11,021,747 · App. 16/575,610 · Granted Jun 1, 2021

Method for nanopore RNA characterisation

Inventors: Daniel Ryan Garalde (Oxford, GB); Andrew John Heron (Oxford, GB); Lakmal Jayasinghe (Oxford, GB); Daniel John Turner (Oxford, GB); James White (Oxford, GB)
Assignee: Oxford Nanopore Technologies Ltd.
C12Q1/6869C12N9/14C12Y306/04012G01N27/44791G01N33/48721C12Q2565/631
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,021,747
App. No.
16/575,610
Filed
Sep 19, 2019
Granted
Jun 1, 2021
Kind
B2
Art Unit
1634
USPC
435/6.1
Abstract

The invention relates to a new method of characterising a target RNA polynucleotide by taking one or more measurements as the target RNA polynucleotide moves with respect to a transmembrane pore. The movement is controlled by a DNA helicase. The invention also relates to a modified RNA construct wherein the RNA polynucleotide has been modified to increase DNA helicase binding thereto.

Claims (27)

1. A method of characterising a target RNA polynucleotide comprising:

(a) providing (i) an RNA polynucleotide that is modified to comprise a single stranded DNA polynucleotide and (ii) a helicase enzyme, wherein the single stranded DNA polynucleotide provides a binding site for the helicase enzyme;

(b) contacting the RNA polynucleotide and helicase enzyme provided in (a) with a transmembrane pore such that the helicase enzyme controls the movement of the RNA polynucleotide through the transmembrane pore;

(c) taking one or more measurements as the RNA polynucleotide moves with respect to the transmembrane pore, wherein the one or more measurements are indicative of one or more characteristics of the RNA polynucleotide, and

thereby characterising the target RNA polynucleotide.

2. A method according to claim 1 , wherein the single stranded DNA polynucleotide comprises a DNA adaptor.

3. A method according to claim 1 , wherein the single stranded DNA polynucleotide comprises a leader sequence.

4. A method according to claim 1 , wherein the single stranded DNA polynucleotide comprises a leader sequence that preferentially threads into the transmembrane pore.

5. A method according to claim 1 , wherein the single stranded DNA polynucleotide is covalently attached to the RNA polynucleotide.

6. A method according to claim 1 , wherein the single stranded DNA polynucleotide is ligated to the RNA polynucleotide.

7. A method according to claim 1 , wherein the single stranded DNA polynucleotide is hybridised to the RNA polynucleotide.

8. A method according to claim 1 , wherein the one or more characteristics are selected from (i) length of the RNA polynucleotide, (ii) identity of the RNA polynucleotide, (iii) the sequence of the RNA polynucleotide, (iv) the secondary structure of the RNA polynucleotide, and (v) whether the RNA polynucleotide is modified.

9. A method according to claim 1 , wherein the one or more measurements are electrical and/or optical measurements.

10. A method according to claim 1 , wherein step c) comprises measuring the current passing through the transmembrane pore as the RNA polynucleotide moves with respect to the transmembrane pore wherein the current is indicative of one or more characteristics of the RNA polynucleotide and thereby characterising the RNA polynucleotide.

11. A method according to claim 1 , wherein the RNA polynucleotide comprises modification by methylation, modification by oxidation, modification by damage, modification with one or more proteins, modification with base analogues or modification with one or more labels, tags or spacers.

12. A method according to claim 1 , wherein the RNA polynucleotide is coupled to the transmembrane pore using one or more anchors.

13. A method according to claim 1 , wherein the transmembrane pore is a protein pore or a solid state pore.

14. A method according to claim 1 , wherein the transmembrane protein pore is a protein pore, wherein the protein pore is derived from a group selected from hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), MspB, MspC, MspD, CsgG, lysenin, outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP) or WZA.

15. A method of characterising an RNA polynucleotide comprising:

(a) providing (i) an RNA polynucleotide that is modified to comprise a single stranded DNA polynucleotide, (ii) a helicase enzyme, and (iii) one or more molecular brakes that are derived from helicases and are modified such that they bind the polynucleotide but do not function as a helicase;

(b) contacting the modified RNA polynucleotide and helicase enzyme provided in (a) with a transmembrane pore such that the helicase controls the movement of the RNA polynucleotide through the transmembrane pore;

(c) taking one or more measurements as the modified RNA polynucleotide moves with respect to the transmembrane pore, wherein the one or more measurements are indicative of one or more characteristics of the RNA polynucleotide, and

thereby characterising the RNA polynucleotide.

16. A method according to claim 15 , wherein the transmembrane pore is a protein pore or a solid state pore.

17. A method according to claim 15 , wherein the transmembrane protein pore is a protein pore, wherein the protein pore is derived from a group selected from hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), MspB, MspC, MspD, CsgG, lysenin, outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP) or WZA.

18. A method according to claim 15 , wherein the single stranded DNA polynucleotide comprises a DNA adaptor.

19. A method according to claim 15 , wherein the single stranded DNA polynucleotide comprises a leader sequence that preferentially threads into the transmembrane pore.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2020
From: GARALDE, DANIEL RYAN; HERON, ANDREW JOHN; JAYASINGHE, LAKMAL; TURNER, DANIEL JOHN; WHITE, JAMES
To: OXFORD NANOPORE TECHNOLOGIES LTD.
Reel/Frame 051958/0043 →
Priority Claims (3)
GB 1418459 · Oct 17, 2014 · national
GB 1508270 · May 14, 2015 · national
GB 1517634 · Oct 6, 2015 · national
Continuity (3)
Continuation 15519599
Continuation In Part PCTGB2015052916 · Oct 6, 2015
Related Publication 20200063199A1 · Feb 27, 2020
Cited By (9)
US 12,227,800 US 12,258,375 US 12,275,761 US 12,371,458 US 12,473,593 US 12,662,703 US 12,679,872 US 12,686,886 US 12,716,094